These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 25226529)

  • 1. A comprehensive review and update on the non-biologic treatment of adult noninfectious uveitis: part I.
    Lee K; Bajwa A; Freitas-Neto CA; Metzinger JL; Wentworth BA; Foster CS
    Expert Opin Pharmacother; 2014 Oct; 15(15):2141-54. PubMed ID: 25226529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive review and update on the biologic treatment of adult noninfectious uveitis: part II.
    Lee K; Bajwa A; Freitas-Neto CA; Metzinger JL; Wentworth BA; Foster CS
    Expert Opin Biol Ther; 2014 Nov; 14(11):1651-66. PubMed ID: 25226284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging drugs for the treatment of uveitis.
    Leung TG; Thorne JE
    Expert Opin Emerg Drugs; 2013 Dec; 18(4):513-21. PubMed ID: 24274613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Road to remission: a comprehensive review of therapy in uveitis.
    Siddique SS; Shah R; Suelves AM; Foster CS
    Expert Opin Investig Drugs; 2011 Nov; 20(11):1497-515. PubMed ID: 21936708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging drugs for the treatment of noninfectious uveitis.
    Pleyer U; Pohlmann D; Kardeş E; Poddubnyy D; Rademacher J
    Expert Opin Emerg Drugs; 2019 Sep; 24(3):173-190. PubMed ID: 31498689
    [No Abstract]   [Full Text] [Related]  

  • 6. The Ocular Immunology and Uveitis Foundation preferred practice patterns of uveitis management.
    Foster CS; Kothari S; Anesi SD; Vitale AT; Chu D; Metzinger JL; Cerón O
    Surv Ophthalmol; 2016; 61(1):1-17. PubMed ID: 26164736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Side-effects of anti-inflammatory therapy in uveitis.
    Uchiyama E; Papaliodis GN; Lobo AM; Sobrin L
    Semin Ophthalmol; 2014; 29(5-6):456-67. PubMed ID: 25325874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapy of uveitis.
    Lee FF; Foster CS
    Expert Opin Pharmacother; 2010 May; 11(7):1135-46. PubMed ID: 20367272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of noninfectious uveitis.
    Ferreira LB; Farrall AL; Furtado JM; Smith JR
    Arq Bras Oftalmol; 2021; 84(6):610-621. PubMed ID: 34431877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in the pharmacotherapy of uveitis: the art of personalized care.
    Patel SH; Belamkar A; Hajrasouliha AR; Jusufbegovic D; Ciulla TA
    Expert Opin Pharmacother; 2022 Aug; 23(12):1445-1455. PubMed ID: 35880543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone for ocular inflammation.
    Saraiya NV; Goldstein DA
    Expert Opin Pharmacother; 2011 May; 12(7):1127-31. PubMed ID: 21457057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment strategies for childhood noninfectious chronic uveitis: an update.
    Cantarini L; Simonini G; Frediani B; Pagnini I; Galeazzi M; Cimaz R
    Expert Opin Investig Drugs; 2012 Jan; 21(1):1-6. PubMed ID: 22074394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of ocular inflammation in children.
    Thadani SM; Foster CS
    Paediatr Drugs; 2004; 6(5):289-301. PubMed ID: 15449968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical approach to the use of corticosteroids in patients with uveitis.
    Cunningham ET; Wender JD
    Can J Ophthalmol; 2010 Aug; 45(4):352-8. PubMed ID: 20648092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of systemic therapy for noninfectious uveitis.
    Ormaechea MS; Hassan M; Onghanseng N; Park JH; Mahajan S; Al-Kirwi KY; Uludag G; Halim MS; Schlaen A; Sepah YJ; Do DV; Nguyen QD
    Expert Opin Drug Saf; 2019 Dec; 18(12):1219-1235. PubMed ID: 31801415
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of sight-threatening uveitis: new therapeutic options.
    Becker MD; Smith JR; Max R; Fiehn C
    Drugs; 2005; 65(4):497-519. PubMed ID: 15733012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-world evidence of treatment for relapse of noninfectious uveitis in tertiary centers in Japan: A multicenter study.
    Takeuchi M; Kanda T; Kaburaki T; Tanaka R; Namba K; Kamoi K; Maruyama K; Shibuya E; Mizuki N
    Medicine (Baltimore); 2019 Mar; 98(9):e14668. PubMed ID: 30817592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uveitis Therapy: The Corticosteroid Options.
    Valdes LM; Sobrin L
    Drugs; 2020 Jun; 80(8):765-773. PubMed ID: 32350761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current and Emerging Pharmaceutical Therapies for Noninfectious Uveitis.
    Kodati S; Weng CY
    Int Ophthalmol Clin; 2019; 59(1):111-126. PubMed ID: 30585921
    [No Abstract]   [Full Text] [Related]  

  • 20. Systemic immunosuppressive therapies for uveitis in developing countries.
    Agrawal H; Doan H; Pham B; Khosla A; Babu M; McCluskey P; Nguyen QD; Sangwan V; Reddy S; Sawhney S; Tyagi M
    Indian J Ophthalmol; 2020 Sep; 68(9):1852-1862. PubMed ID: 32823402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.